Cargando…

Allergic Rhinitis in Childhood and the New EUFOREA Algorithm

Allergic rhinitis in childhood has been often missed, mistreated and misunderstood. It has significant comorbidities, adverse effects upon quality of life and educational performance and can progress to asthma or worsen control of existing asthma. Accurate diagnosis and effective treatment are impor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scadding, Glenis Kathleen, Smith, Peter Kenneth, Blaiss, Michael, Roberts, Graham, Hellings, Peter William, Gevaert, Philippe, Mc Donald, Marinda, Sih, Tania, Halken, Suzanne, Zieglmayer, Petra Ursula, Schmid-Grendelmeier, Peter, Valovirta, Erkka, Pawankar, Ruby, Wahn, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974858/ https://www.ncbi.nlm.nih.gov/pubmed/35387065 http://dx.doi.org/10.3389/falgy.2021.706589

Ejemplares similares

EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]
por: Scadding, Glenis K, et al.
Publicado: (2023)

White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA
por: De Prins, Louise, et al.
Publicado: (2022)

EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care
por: Hellings, P. W., et al.
Publicado: (2023)

Corrigendum on: White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA
por: De Prins, Louise, et al.
Publicado: (2022)

Survey on the impact of comorbid allergic rhinitis in patients with asthma
por: Valovirta, Erkka, et al.
Publicado: (2006)

Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement
por: Scadding, Glenis K., et al.
Publicado: (2020)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
por: Van Broeck, Dorien, et al.
Publicado: (2023)

Determinants of uncontrolled allergic rhinitis in Kinshasa hospitals
por: Kakobo, Patricia K., et al.
Publicado: (2023)

A EUFOREA comment on a lost comorbidity of asthma
por: Conti, Diego M., et al.
Publicado: (2023)

Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA
por: Claeys, N., et al.
Publicado: (2021)

Corrigendum: Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA
por: Claeys, N., et al.
Publicado: (2021)

Editorial: Insights in rhinology: 2021/22
por: Smith, Peter Kenneth, et al.
Publicado: (2023)

Optimal management of allergic rhinitis
por: Scadding, Glenis K
Publicado: (2015)

Pathophysiological and Clinical Aspects of Chronic Rhinosinusitis: Current Concepts
por: Vlaminck, Stephan, et al.
Publicado: (2021)

Grand Challenges in Rhinology
por: Scadding, Glenis K.
Publicado: (2020)

A New Grand Challenge in Rhinology: An Intranasal COVID Vaccine
por: Scadding, Glenis Kathleen
Publicado: (2022)

EUFOREA Comment on a Misleading Allergic Rhinitis Report [Response to Letter]
por: Fifer, Simon, et al.
Publicado: (2023)

MP29-02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis
por: Scadding, Glenis, et al.
Publicado: (2015)

Diagnostic Tools in Allergic Rhinitis
por: Testera-Montes, Almudena, et al.
Publicado: (2021)

Managing Co-Morbid Asthma With Allergic Rhinitis: Targeting the One-Airway With Leukotriene Receptor Antagonists
por: Valovirta, Erkka
Publicado: (2012)

Short and long-term safety of MP29-02*: a new therapy for the treatment of allergic rhinitis
por: Price, David, et al.
Publicado: (2013)

A new therapy (MP29-02*) effectively targets the entire seasonal allergic rhinitis symptom complex
por: Price, David, et al.
Publicado: (2013)

Precision Medicine in Mite Allergic Rhinitis
por: González-Pérez, Ruperto, et al.
Publicado: (2021)

Profile of aeroallergen sensitizations in allergic patients living in southern Vietnam
por: Trinh, Tu HK, et al.
Publicado: (2023)

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
por: Scadding, Glenis, et al.
Publicado: (2013)

A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies
por: Hellings, Peter, et al.
Publicado: (2015)

Mechanism and clinical evidence of immunotherapy in allergic rhinitis
por: De Carli, Marco, et al.
Publicado: (2023)

A new therapy (MP29-02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis
por: Hellings, Peter, et al.
Publicado: (2013)

A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29-02*
por: Bousquet, Jean, et al.
Publicado: (2013)

Is endoscopic sinus surgery sufficient to modify the evolution of adult AERD? Aspirin desensitization as a maintenance factor: systematic review
por: Conti, Diego M., et al.
Publicado: (2023)

A new therapy (MP29-02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion
por: Bachert, Claus, et al.
Publicado: (2013)

The Effect of Seasonal Priming on Specific Inhalation Challenges With Birch and Grass Allergen Among Persons With Allergic Rhinitis
por: Ørby, Pia V., et al.
Publicado: (2021)

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated
por: Kariyawasam, Harsha H, et al.
Publicado: (2010)

Control of allergic rhinitis in four latin american countries: Rinola study
por: Silva, Diana L, et al.
Publicado: (2022)

Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement
por: Hellings, P. W., et al.
Publicado: (2019)

Pattern of Aeroallergen Sensitization and Quality of Life in Adult Thai Patients With Allergic Rhinitis
por: Katel, Puspalal, et al.
Publicado: (2021)

Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?
por: Boonpiyathad, Tadech, et al.
Publicado: (2021)

Using magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitis
por: Leaker, Brian R., et al.
Publicado: (2015)

Der p 1 Disrupts the Epithelial Barrier and Induces IL-6 Production in Patients With House Dust Mite Allergic Rhinitis
por: Ogi, Kazuhiro, et al.
Publicado: (2021)

Cholinergic Synapse Pathway Gene Polymorphisms Associated With Late-Phase Responses in Allergic Rhinitis
por: Samra, Simranjit K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s15c232fjv8i9ave1j8add0qrr